ConCallIQ
Go Pro
Home › Ajanta Pharma › Revenue History

Ajanta Pharma Revenue History — Quarter by Quarter

Ajanta Pharma's revenue moved from ₹1,354 Cr in Q2 FY26 to ₹1,422 Cr in Q4 FY26, a 5.0% change over 3 quarters. The table keeps each quarter linked back to the underlying earnings page.

Revenue by Quarter

QuarterRevenue (₹ Cr)YoY Change
Q4 FY26₹1,422 Cr+21%
Q3 FY26₹1,375 Cr+20%
Q2 FY26₹1,354 Cr+14%

What management said about revenue

G

Q4 FY26 · Revenue growth 16-18% for FY27

Overall company revenue expected to grow 16-18% in FY27, driven by high double-digit growth in Asia and Africa branded generics, mid-single-digit US growth, and India outperformance.

G

Q3 FY26 · GLP-1 launch in India in March 2026

Company plans to launch GLP-1 products in India under own brand in March 2026, being in the first wave.

G

Q2 FY26 · US generics growth to sustain at current run-rate

Management expects US generics to maintain the current quarterly run-rate of ~₹343 crore for the next two quarters.

G

Q2 FY26 · Africa business upgraded to double-digit growth for FY26

Management upgraded Africa growth guidance from mid-single-digit to double-digit for the full year, citing favorable base effect.